Please use this identifier to cite or link to this item: http://hdl.handle.net/1843/56036
Type: Artigo de Periódico
Title: Azithromycin for the treatment of eosinophilic nasal polyposis: clinical and histologic analysis
Authors: Isamara Simasde Oliveira
Paulo Fernando Tormin Borges Crosara
Geovanni Dantas Cassali
Diego Carlos Dos Reis
Danilo Santana Rodrigues
Flavio Barbosa Nunes
Roberto Eustáquio Santos Guimarães
Abstract: Introduction: Macrolides used as immunomodulators are a promising tool for chronic inflammatory airway diseases.Eosinophilic nasal polyposis (ENP) is still considered a disease that is difficult to control with the currently standardized treatments.Objectives: To evaluate prolonged treatment with low-dose azithromycin for ENP based on clinical and histopathologic variables.Methods: The present investigation was a self-paired case study of 33 patients with ENP. A comparison was performed between patients before and after treatment with azithromycin for 8 weeks. The patients were subjected to clinical examinations,staging (three-dimensional imaging by endoscopy), application of the questionnaire, and biopsy of nasal polyps at the beginning and at the end of the treatment. Results: The treatment yielded a clinical improvement regarding the two variables studied: polyposis staging (69.7%) and questionnaire (57.6%). We did not find significant differences in the inflammatory pattern and in the percentage or absolute number of eosinophils per field between samples obtained before and after the treatment (p > 0.05). There was no difference between the answers obtained from groups with and without asthma and/or aspirin intolerance (p>0.3). The patients with advanced initial staging exhibited lower subjective improvement index and staging reduction (p> 0.031 and p > 0.012, respectively). Conclusion: Based on this study, azithromycin may be considered as another therapeutic option for ENP. However, further studies are necessary to define the real mechanism of action involved.
Subject: Macrolídeos
Pólipos nasais
Azitromicina
Eosinófilos
language: por
metadata.dc.publisher.country: Brasil
Publisher: Universidade Federal de Minas Gerais
Publisher Initials: UFMG
metadata.dc.publisher.department: ICB - DEPARTAMENTO DE PATOLOGIA
MED - DEPARTAMENTO DE OFTALMOLOGIA E OTORRINOLARINGOLOGIA
Rights: Acesso Aberto
metadata.dc.identifier.doi: https://doi.org/10.2500/ar.2016.7.0160
URI: http://hdl.handle.net/1843/56036
Issue Date: 2016
metadata.dc.url.externa: https://journals.sagepub.com/doi/full/10.2500/ar.2016.7.0160?rfr_dat=cr_pub++0pubmed&url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org
metadata.dc.relation.ispartof: Therapeutic Advances in Allergy and Rhinology
Appears in Collections:Artigo de Periódico

Files in This Item:
File Description SizeFormat 
Azithromycin for the treatment of eosinophilic nasal pdfa.pdf111.15 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.